Peoples Financial Q2: Net Income and EPS Fall as Deposits Slide; Capital, Dividend Intact

Peoples Financial Corporation (NASDAQ: PFBX) - quick read on what's happening inside

Snapshot - key facts & figures (as reported June 30, 2025 vs comparable dates)
- Net income Q2 2025: $1,242,000 (Q2 2024: $2,329,000).
- Net income six months 2025: $2,552,000 (six months 2024: $4,744,000).
- EPS Q2 2025: $0.27 (Q2 2024: $0.50). Six months EPS 2025: $0.55 (2024: $1.02).
- Net interest income Q2 2025: $5,472,000 (Q2 2024: $5,903,000). Total interest income Q2: $7,464,000 (Q2 2024: $8,695,000).
- Non-interest income Q2 2025: $1,777,000 (Q2 2024: $1,761,000). Non-interest expense Q2 2025: $5,762,000 (Q2 2024: $5,564,000).
- Income before taxes Q2 2025: $1,487,000 (Q2 2024: $2,100,000). Income tax expense Q2 2025: $245,000 (Q2 2024: $(229,000)).
- Total assets June 30, 2025: $761,340,000 (Dec 31, 2024: $831,849,000).
- Total deposits June 30, 2025: $644,311,000 (Dec 31, 2024: $720,730,000) - down $76.4M.
- Cash and due from banks June 30, 2025: $18,379,000 (Dec 31, 2024: $107,744,000) - down $89.4M.
- Loans (gross) June 30, 2025: $248,298,000 (Dec 31, 2024: $233,576,000). Loans, net: $245,332,000 (Dec 31, 2024: $230,594,000).
- Allowance for credit losses on loans: $2,966,000 (Dec 31, 2024: $2,982,000). Allowance / loans = 1.19% (June 30, 2025) vs 1.28% (Dec 31, 2024).
- Nonaccrual loans: $600,000 (June 30, 2025) vs $418,000 (Dec 31, 2024).
- Available-for-sale securities fair value: $336,973,000 (amortized cost $367,812,000) - unrealized losses $30,985,000 (improved from $37,481,000 at 12/31/24).
- Held-to-maturity securities amortized cost: $100,896,000; fair value $90,063,000; allowance on HTM securities: $40,000.
- Shareholders' equity: $96,510,000 (June 30, 2025) up from $90,001,000 (Dec 31, 2024).
- Accumulated other comprehensive loss improved to $(32,099,000) from $(36,887,000).
- Dividend maintained: $0.18 per share (declared and paid).
- Community bank leverage ratio: 13.97% (June 30, 2025) and 13.95% (Dec 31, 2024) - comfortably above the 9.00% CBLR threshold.

What's happening inside - concise analysis
- Funding shift and deposit outflows drove activity: the bank lost meaningful public fund deposit balances (competitive bid losses and tax allocations), producing a large drop in deposits (~$76M) and a big reduction in cash balances (~$89M). Management used borrowings and securities repositioning to manage liquidity (HTM down, AFS purchases up).
- Core lending grew: gross loans rose ~$14.7M year-to-date; loan mix remains concentrated in real estate (residential + nonresidential). Nonaccruals ticked up to $600K, but remain small relative to the portfolio; ACL coverage modest at ~1.19% of loans.
- Profitability down vs prior year: lower interest income (smaller investment balances and lower yields) and higher non-interest expense compressed pre-tax earnings. Taxes increased materially (prior-year tax credits largely used in 2024), adding pressure to net income.
- Capital and liquidity remain solid: equity increased, CBLR ratio strong (~14%), access to FHLB and Fed Discount Window intact, and the bank maintains contingency borrowing lines.

Income statement - positives
- Net interest margin held up: tax-equivalent NIM improved to 3.01% (Q2 2025) vs 2.89% a year earlier - showing margins were defended despite lower earning asset volumes.
- Interest expense fell: total interest expense dropped to $1,992,000 (Q2 2025) from $2,792,000 (Q2 2024), reflecting lower average interest-bearing liabilities and reduced short-term funding costs.
- Non-interest income stable: service charges and trust income ticked up; no material reliance on volatile one-time gains in Q2 2025.
- Dividend continuity: board kept the $0.18/share dividend, signaling confidence in capital and cash generation.

Income statement - negatives / risks
- Revenue pressure: total interest income fell sharply (Q2 interest income $7.464M vs $8.695M LY) as securities and fed balances shrank and yields on some assets declined.
- Rising operating costs: non-interest expense increased (Q2 +$198K YoY), driven by higher salaries, ATM and data processing costs - these reduced operating leverage.
- Lower net income and EPS: Q2 net income down ~47% YoY and EPS down from $0.50 to $0.27 - notable deterioration that investors will question.
- Elevated unrealized losses in securities: AFS unrealized loss remains material ($30.985M), which can swing OCI and equity with market moves (already reduced OCI loss but still significant).
- Deposit concentration / public funds volatility: loss of public fund accounts and timing of tax flows create recurring volatility in deposits and liquidity - management says they don't expect a liquidity shortfall but this is a recurring operational risk.
- Taxes: effective tax rate rose (Q2 17% vs (11)% prior year) as tax credits were utilized in 2024; taxes are a larger drag on 2025 earnings.

Operational notes & governance
- Management continues active portfolio monitoring (CECL processes in place); ACL essentially stable with small provision activity (net provision of $(5k) YTD).
- Litigation / shareholder activism: ongoing proxy/derivative dispute with an activist investor (Stilwell); limited discovery ordered - a governance risk to watch.
- Liquidity toolkit: $111.7M available FHLB line, Federal Reserve discount window access, and other contingency lines; management is emphasizing contingency planning.

Bottom line / short take
Peoples Financial (NASDAQ: PFBX) is navigating a quarter of transition: deposit volatility (loss of public funds and tax-related flows) shrank cash and securities balances, pressuring interest income and causing negative year-over-year net income and EPS movement. Offsets: loan growth, maintained dividend, improved NIM and stronger shareholders' equity and capital ratios. Key near-term watch items are deposit stability (public funds), control of operating costs, the level of unrealized losses in the securities portfolio, and any escalation in the shareholder litigation. Management's liquidity and capital buffers are adequate today, but revenue recovery and expense control will determine whether earnings normalize in the coming quarters.

If you want, I can pull and chart the items that matter most (deposits, cash, NII, non-interest expense, ACL and nonaccruals) for a clearer trend view.